Mobilizing the Community to Reduce Teen Prescription Drug Abuse

动员社区减少青少年处方药滥用

• 批准号: 7739152
• 负责人: DAVID COLLINS
• 金额: $ 20.03万
• 依托单位: PACIFIC INSTITUTE FOR RES AND EVALUATION
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-08-01 至 2011-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7739152
• 关键词: 13 year old; 17 year old; Address; Advocacy; Advocate; Alaska; Analgesics; Child; Communities; County; Data; Drug Prescriptions; Environment; Family member; Feasibility Studies; Friends; Funding; High Prevalence; Home environment; Household Products; Inhalant dose form; Intervention; Legal; Long-Term Effects; Mediating; Medical; Methods; Modeling; National Institute of Drug Abuse; Needs Assessment; Non-Prescription Drugs; Outcome; Parents; Patients; Persons; Pharmaceutical Preparations; Pharmacists; Pharmacy facility; Physicians; Physicians' Offices; Policies; Prevalence; Prevention; Prevention approach; Preventive Intervention; Public Health; Regulation; Reporting; Research; Research Design; Respondent; Role; Schools; Signal Transduction; Source; Students; Surveys; Teenagers; Tennessee; Time; United States Substance Abuse and Mental Health Services Administration; Writing; Youth; base; design; directed attention; dosage; drug abuse prevention; evidence base; innovation; interest; intervention effect; non-drug; post intervention; prescription drug abuse; prevent; public health relevance

DESCRIPTION (provided by applicant): Teen prescription drug abuse is a significant and growing problem. The latest national figures show that over 15% of 12th graders in the U.S. used at least one type of prescription drug for non-medical use in the past year. Research has shown that prescription drugs that can be abused are often readily available to teens either from family members in the home or from friends. This R21 application builds on previous research and proposes a two-year feasibility study to adapt and implement an integrated community prevention model (to include community mobilization, a home environmental strategy, and a medical environmental strategy) to reduce the availability of prescription drugs in the home for abuse by teens. The research setting will be one county in Southern Appalachian Tennessee in which prescription drug abuse is reported to be a problem. Our proposed environmental strategies will incorporate learnings from a recent NIDA-funded integrated community prevention model that was implemented in Alaska to reduce availability of harmful legal products (inhalants, over-the-counter drugs, household products, and prescription drugs). The specific aims are to (1) adapt and implement an integrated community prescription drug abuse prevention model that targets prescription drug abuse among teens, and (2) assess change in proximal outcomes (community engagement, advocacy by physicians' office and pharmacy staff, and the availability of prescription drugs in the home) believed to mediate intervention effects on teen prescription drug abuse. We will also assess what aspects of implementation quality (e.g., reach, dosage, fidelity) may explain the change. The research design for assessing change in the proximal outcome of teens' perceived availability of prescription drugs for abuse is a pre-post intervention-group-only design that will utilize data from a panel of students in grades 5, 7, 9, and 11 at baseline who will be surveyed at two time points in consecutive school years. Analyses of the other proximal outcomes will utilize data from participating parents, physicians' office staff, and pharmacy staff who participate in environmental strategies. Activities in both the home environmental strategy and the medical environmental strategy will be directed toward reducing availability of prescription drugs for abuse by teens in the home. Based on learnings from previous research, key contributing factors are posited to be norms, including concern over the problem of teen prescription drug abuse, and rules, regulations and policies. Our proposed set of complementary approaches, including a medical environmental strategy designed to support the home environmental strategy, represents a new and innovative prevention approach to the problem of teen prescription abuse. The significance of this study is its potential to adapt an integrated community prevention model to help prevent teens' abuse of prescription drugs. PUBLIC HEALTH RELEVANCE: Prescription drug abuse among teens is a significant and growing problem. This study seeks to adapt and implement an integrated community prevention model including community mobilization and environmental strategies (a medical environmental strategy designed to support a home environmental strategy) focused on reducing availability of these drugs in the home. If the approach is successful, it could help address this serious public health problem.

描述（由申请人提供）：青少年处方药滥用是一个严重且日益严重的问题。最新的全国数据显示，超过 15% 的美国 12 年级学生在过去一年中至少使用过一种非医疗用途处方药。研究表明，青少年通常很容易从家里的家人或朋友那里获得可能被滥用的处方药。该 R21 应用程序以之前的研究为基础，提出了一项为期两年的可行性研究，以适应和实施综合社区预防模式（包括社区动员、家庭环境策略和医疗环境策略），以减少青少年在家中滥用处方药的情况。研究地点将是田纳西州南阿巴拉契亚地区的一个县，据报道该县存在处方药滥用问题。我们提出的环境战略将纳入最近由 NIDA 资助的综合社区预防模型的经验教训，该模型在阿拉斯加实施，旨在减少有害合法产品（吸入剂、非处方药、家用产品和处方药）的供应。具体目标是 (1) 调整和实施针对青少年处方药滥用的综合社区处方药滥用预防模型，以及 (2) 评估近期结果的变化（社区参与、医生办公室和药房工作人员的宣传以及家庭处方药的可用性），这些变化被认为可以调节对青少年处方药滥用的干预效果。我们还将评估实施质量的哪些方面（例如范围、剂量、保真度）可以解释这一变化。用于评估青少年对滥用处方药的感知可用性的近期结果变化的研究设计是一项仅针对干预前组的设计，该设计将利用基线时 5、7、9 和 11 年级学生小组的数据，这些学生将在连续学年的两个时间点接受调查。其他近期结果的分析将利用参与环境策略的家长、医生办公室工作人员和药房工作人员的数据。家庭环境战略和医疗环境战略的活动将旨在减少青少年在家中滥用处方药的机会。根据之前的研究，关键的影响因素被认为是规范，包括对青少年处方药滥用问题的担忧以及规则、法规和政策。我们提出的一套补充方法，包括旨在支持家庭环境策略的医疗环境策略，代表了针对青少年处方滥用问题的一种新的创新预防方法。这项研究的意义在于它有可能采用综合社区预防模式来帮助防止青少年滥用处方药。公共卫生相关性：青少年滥用处方药是一个严重且日益严重的问题。本研究旨在适应和实施综合社区预防模式，包括社区动员和环境策略（旨在支持家庭环境策略的医疗环境策略），重点是减少这些药物在家庭中的可用性。如果该方法成功，将有助于解决这一严重的公共卫生问题。